Evidence map›Paper›PMID 41920227›Full record

ArticleMolecular biology reports2026

Mutation mapping and functional characterization of a missense mutation p.Arg228Cys in ALDH3A2 gene causing Sjögran-Larson syndrome.

Muhammad Zeeshan Ali, Samia Sattar, Abdulfatah M Alayoubi, Shakil Abbas, Mohammed Turki Hussain Alharthi, Alwaleed Fahad H Altemani, Muhammad Latif, Muzammil Ahmad Khan, Christian Windpassinger

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Muhammad Zeeshan AliGomal Centre of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan (D.I. Khan), 29050, Khyber Pakhtunkhwa, Pakistan.
Samia SattarGomal Centre of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan (D.I. Khan), 29050, Khyber Pakhtunkhwa, Pakistan.
Abdulfatah M AlayoubiDepartment of Basic Medical Sciences, College of MedicineTaibah University, Madinah, 42353, Saudi Arabia.
Shakil AbbasGomal Centre of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan (D.I. Khan), 29050, Khyber Pakhtunkhwa, Pakistan.
Mohammed Turki Hussain AlharthiDepartment of Basic Medical Sciences, College of MedicineTaibah University, Madinah, 42353, Saudi Arabia.
Alwaleed Fahad H AltemaniHistocompatibility and Immunogenetics Laboratory, Organ Transplant Center, King Faisal Specialist Hospital and Research Centre (KFSH & RC), Riyadh, Saudi Arabia.
Muhammad Latif *Department of Basic Medical Sciences, College of MedicineTaibah University, Madinah, 42353, Saudi Arabia.
Muzammil Ahmad Khan *Gomal Centre of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan (D.I. Khan), 29050, Khyber Pakhtunkhwa, Pakistan. m.ahmad@gu.edu.pk.
Christian Windpassinger *Diagnostic and Research Institute of Human Genetics, Medical University of Graz, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study examined a consanguineous family affected by autosomal recessive Sjögren-Larsson syndrome (SLS) that is characterized by congenital ichthyosis, intellectual disabilities, and spastic diplegia. SLS is a rare inborn error of lipid metabolism resulting from mutations in the ALDH3A2 gene, leading to a deficiency in the fatty aldehyde dehydrogenase (FALDH) enzyme. METHODS AND

resultsWe employed homozygosity-by-descent (HBD) mapping followed by whole-exome sequencing (WES) for mutation identification and conducted protein structure modeling and enzyme assays to determine the functional consequences of the mutation. HBD mapping and WES in a patient with SLS identified a recurrent missense mutation NM_000382:c.C682T: p.(Arg228Cys) in the 5th exon of the ALDH3A2 gene. Protein structural modeling and docking studies indicated significant alterations in the structural and interactional properties of the mutant ALDH3A2. Enzyme analysis of serum extracts revealed reduced ALDH enzyme activity in both affected and carrier individuals.

conclusionThis study confirmed the association between diminished ALDH activity and the severity of clinical manifestations, including developmental delay, ichthyosis, spasticity, and cognitive disability. To our knowledge, this is the first report of an ALDH3A2 mutation in a Pakistani family. Our findings reinforce evidence that the NM_000382:c.C682T: p.(Arg228Cys) mutation in ALDH3A2 is causative of SLS, underscoring the importance of genetic counseling and early biochemical diagnosis for families at risk of SLS.

Indexed as

Aldehyde OxidoreductasesMutation, MissenseSjogren-Larsson SyndromeChildConsanguinityExome SequencingFemaleHumansMalePakistanPedigreeAldehyde Oxidoreductaseslong-chain-aldehyde dehydrogenaseALDH3A2Enzyme activityExome sequencingPakistani familyPrenatal testingSjögren-Larsson Syndrome

Identifiers

PMID41920227

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.